CONMED CORPORATION Operating Lease Right-of-Use Assets
CONMED CORPORATION (CNMD) had Operating Lease Right-of-Use Assets of $48.99 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-02-17
- 2025-12-31: Operating Lease, Right-of-Use Asset $48.99M.
- 2024-12-31: Operating Lease, Right-of-Use Asset $39.84M.
- 2023-12-31: Operating Lease, Right-of-Use Asset $16.61M.
- 2022-12-31: Operating Lease, Right-of-Use Asset $17.71M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-12-31 | $48.99M 10-K · filed 2026-02-17 |
| 2024-12-31 | $39.84M 10-K · filed 2026-02-17 |
| 2023-12-31 | $16.61M 10-K · filed 2025-02-18 |
| 2022-12-31 | $17.71M 10-K · filed 2024-02-28 |
| 2021-12-31 | $19.43M 10-K · filed 2023-02-21 |
| 2020-12-31 | $21.66M 10-K · filed 2022-02-22 |
| 2019-12-31 | $23.10M 10-K · filed 2021-02-22 |
| 2019-09-30 | $17.68M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $14.94M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $16.28M 10-Q · filed 2019-04-26 |
| 2019-01-01 | $17.90M 10-Q · filed 2019-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |